Generic Cortrosyn Injection Launched; Screens for Adrenocortical Insufficiency

InnoPharma announced the launch of Cosyntropin Injection, the generic version of Amphastar's Cortrosyn. Cortrosyn injection is a synthetic ACTH intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.

Cosyntropin acts similarly to that of purified natural ACTH, a hormone produced in the pituitary gland that stimulates the adrenal glands.  The injection produces maximal secretion of 17-OH corticosteroids, 17-ketosteroids and/or 17-ketogenic steroids.

Cosyntropin Injection is available in 0.25mg/vial strength in single-use vials.

For more information call (732) 885-2939 or visit www.innopharmainc.com